Trial comparing azathioprine and penicillamine in treatment of rheumatoid arthritis [proceedings]. 1976

H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger

UI MeSH Term Description Entries
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
July 1974, Annals of the rheumatic diseases,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
August 1974, Postgraduate medical journal,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
November 1974, Annals of the rheumatic diseases,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
December 1981, Arthritis and rheumatism,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
October 1984, Danish medical bulletin,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
November 1973, Annals of the rheumatic diseases,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
July 1973, Annals of the rheumatic diseases,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
August 1979, The Ohio State medical journal,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
December 1976, Annals of the rheumatic diseases,
H Berry, and S Liyanage, and R Durance, and C G Barnes, and L Berger
September 1974, JAMA,
Copied contents to your clipboard!